Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MKRN2OS (MKRN2 opposite strand) is a gene located on human chromosome 3 that encodes an RNA molecule, with protein-coding status debated; it is also known as C3orf83, MKRN2-AS1, and MKRN2 antisense RNA 1[6][9]. The available evidence indicates *MKRN2OS* is a distinct genetic locus from *MKRN2*, though its functional and therapeutic characterization remains limited and incomplete. MKRN2OS (MKRN2 opposite strand) is a gene located on chromosome 3, transcribed in the antisense orientation to the MKRN2 gene[6][9]. It has also been known as C3orf83 and MKRN2-AS1, and historical annotations conflict about whether it encodes a protein or functions solely as a long non-coding RNA[9]. Human databases (such as GeneCards and NCBI) now primarily classify MKRN2OS as a gene that may produce a non-coding RNA transcript, though certain entries have described a hypothetical or predicted protein product called "MKRN2 opposite strand protein"[6][9]. Current knowledge indicates a lack of clear evidence that this gene represents a validated therapeutic target such as a receptor, enzyme, channel, or transporter. Expression data suggests MKRN2OS may have a functional role in adipogenesis and lipid metabolism, though evidence remains preliminary and no direct mechanistic role or therapeutic targeting has been validated[4]. Disease database associations link MKRN2OS variants to rare inherited retinal diseases, but its pathogenic mechanisms, if any, remain speculative[9]. There are no reported drug interactions, biomarkers, or established safety concerns; overall, current resources do not support MKRN2OS as an established therapeutic target. Key clarifications: - *MKRN2OS is frequently confused with MKRN2 (Makorin Ring Finger Protein 2), which is a well-studied E3 ligase and cell regulatory protein[5][7], but MKRN2OS is a distinct gene and not a canonical drug target*. - *Most sources classify MKRN2OS as a non-coding RNA or potential lncRNA; proteomic and mechanistic data supporting it as a functional protein or validated drug target are currently lacking or disputed*[6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MKRN2 opposite strand (MKRN2OS).